Zeptomics unlocks the bottleneck of target identification. It identifies probable targets involved in a disease and uncover disease pathways. It can predict possible targets involved in a disease amongst 24 000+ human proteins, and can be used to explain Mechanisms of Action.
Zeptomics can screen billions of molecules to generate a list of safe and potent ligands. Our approach is fast and does not rely on the exact conformation of a protein. It can select molecules that can be quickly synthesized so as to have a wet lab validation within weeks.
Adme-tox and side effects
Zeptomics can predict the ADMETox profile of any ligand - across 88 endpoints. It can predict the risk of off-target effects. It decreases the risk of harmful and non drug-like compounds to go undetected.
Targeted protein degraders
Zeptomics accelerates the discovery of potent and safe Targeted Protein Degraders taking into account both linker, ternary structure creation, and a variety of optimization parameters.
We have a portfolio of models and solutions to develop tailored AI solutions for digital health. This covers disease prediction and diagnosis, automated biomarker analysis.